Trademark Overview
On Friday, February 27, 2026, a trademark application was filed for RETINAI OCT NAVIGATOR with the United States Patent and Trademark Office. The USPTO has given the RETINAI OCT NAVIGATOR trademark a serial number of 79449768. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 7, 2026. This trademark is owned by Ikerian AG. The RETINAI OCT NAVIGATOR trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Application software; embedded operating software; computer hardware and software; computer software for data and document capture, transmission, storage and indexing; computer software platforms; Software as a Medical Device (SaMD).
Computer software development; Platform as a Service (PaaS); Software as a Service (SaaS); design and development of computer hardware and software for medical use; research in the field of artificial intelligence; biomedical research; medical research; scientific research for medical purposes; providing information and data with respect to scientific and technological research and development; scientific and technological services as well as research and development services relating thereto; industrial analysis and industrial research services; data migration services; providing information and data with respect to medical and veterinary research and development.
Remote monitoring of medical data for medical diagnosis and treatment purposes; medical advice; medical examinations; medical information; medical testing services relating to disease diagnosis and treatment; medical information services provided via the Internet; medical testing for the diagnosis and treatment of persons; medical diagnostic services (testing and analysis); provision of medical information; medical services in the field of ophthalmology, including eye diseases and oculomics (namely autoimmune diseases (Graves’ disease, multiple sclerosis (MS)), chronic kidney disease, vascular diseases (diabetes, heart disease, high risk of stroke and hypertension), hereditary diseases (Stargardt disease and retinitis pigmentosa) and neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease)), in particular vision assessment. treatment of vision disorders; professional consultancy in the field of medical technology, medical surgery and orthopedics.
